UK-based clinical contract research organisation Chiltern International has announced further expansion in Europe, with the opening of a new office in Leiden, the Netherlands.
The company, which has its headquarters in Slough, Berkshire, manages phase I-IV clinical trials across a range of therapeutic areas as well as offering functional service provision and contract staffing solutions. It has conducted trials in more than 40 countries since its founding in 1982.
Chiltern has confirmed the appointment of Angela Pasma as Netherlands country manager.
Commenting on the news, Maurizio Passanisi, Chiltern's director of the Benelux Region said: “The Netherlands continues to be an excellent place for clinical research with experienced investigators as well as highly regarded international key opinion leaders, all adhering to the highest of medical standards.
"Furthermore, in leading the growth of the Chiltern office in Leiden, Ms. Pasma brings a wealth of knowledge and experience to support Chiltern's growing full service clinical and flexible staffing services in the region."
Pasma added: "Having already cultivated positive relationships with clients and colleagues in the region, we look forward to expanding our operations here to further serve our clients' needs. The Leiden office is well situated geographically to support this effort."
Armand Czaplinski, executive director, Global Country Management for Chiltern, commented: “Chiltern's expansion in the Netherlands aligns perfectly with our primary goal to deliver expert, high quality services around the world and demonstrates our ongoing commitment to regional expansion in order to serve our clients' needs globally."
Chiltern employs around 1,300 people globally and has offices in Asia Pacific, Europe, Latin America, North America and South Africa.
